Strengthening Translational Research in India: GVSAP and Biocytogen Expand Collaboration
GV Safety Assessment Platform (GVSAP), an integrated preclinical R&D enabler within the GVRP portfolio, today announced an expansion of its strategic collaboration with Biocytogen (SSE: 688796; HKEX: 02315), a global biotechnology company that drives the resear



